Published • loading... • Updated
Health: Saida Partners with Boehringer Ingelheim to Produce Treatments for Pulmonary Fibrosis in Algeria.
Summary by Dzair World
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
The pharmaceutical company Saidal signed a cooperation agreement on Monday in Algiers with the German company Boehringer Ingelheim, aimed at establishing production of an innovative treatment for pulmonary fibrosis in Algeria. The signing ceremony, with the leader in biopharmaceutical research and development, took place at Saidal's production site in El Harrach, under the supervision of the Minister of Pharmaceutical Industry, Wassim Kouidri, a…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
